In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Genzyme Molecular Oncology licenses colon cancer diagnostic
Genzyme Molecular Oncology licenses patent rights
Genzyme Genetics offers two genetic tests
Myriad agrees patent license for cancer diagnostic
New Colon Cancer Gene Licensed Exclusively to Myriad Genetics
Correlogic Systems Licenses Ovarian Cancer Diagnostic Test
IPSOGEN announces exclusive license agreement to the WT1 biomarker from Genzyme Genetics
Myriad Genetics awarded US patent
DIAGNOCURE ACQUIRES NEW HIGH VALUE DIAGNOSTIC TESTS FOR BREAST AND COLON CANCER